|
Market Closed -
Nasdaq
07:00:00 20/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 153.07 USD | -2.00% |
|
+1.75% | +24.71% |
| 19/10 | Gilead Sciences, Inc. Presents New Findings From Its HIV And Antiviral Research And Development Programs At IDWeek 2026 | CI |
| 19/10 | Gilead's pill succeeds in mid-stage bowel disease trial | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.00% | +1.75% | +1.97% | +13.99% | +24.71% | +24.64% | +95.14% | +128.80% | +108.71% | 190B | |
| -1.33% | +4.88% | +7.58% | +5.19% | +15.41% | +54.50% | +109.94% | +411.88% | +1,478.84% | 1,106B | |
| -0.69% | -3.77% | -6.00% | +0.30% | +22.63% | +31.35% | +66.62% | +54.87% | +121.48% | 612B | |
| -0.96% | +0.55% | +7.09% | +11.08% | +23.72% | +23.13% | +94.26% | +163.08% | +360.17% | 500B | |
| +1.41% | +7.31% | +5.84% | +16.40% | +17.64% | +37.35% | +61.55% | +9.63% | +66.06% | 367B | |
| -1.59% | -1.25% | -2.21% | +12.65% | +36.45% | +69.39% | +43.02% | +80.69% | +132.15% | 354B | |
| +0.89% | +5.08% | +7.94% | +1.84% | +14.38% | +20.38% | +47.83% | +61.30% | +66.70% | 286B | |
| +0.39% | +4.69% | -0.84% | +0.60% | -9.69% | -0.88% | +19.41% | +42.04% | +150.21% | 256B | |
| -1.75% | +1.76% | +10.19% | +16.01% | +29.83% | +42.21% | +51.44% | +105.50% | +163.81% | 230B | |
| +0.63% | +0.66% | -0.63% | -21.23% | -20.57% | -28.20% | -61.88% | -22.50% | +85.73% | 170B | |
| -0.47% | +3.66% | +6.44% | +17.52% | +18.23% | +20.11% | -5.61% | -30.05% | -9.69% | 168B | |
| +0.44% | -1.00% | -1.26% | +3.36% | +10.72% | +20.43% | +37.60% | +170.72% | +513.41% | 127B | |
| -1.54% | +2.17% | -6.71% | -3.14% | +9.07% | +34.84% | +4.16% | +2.15% | +17.97% | 120B | |
| +0.56% | +5.72% | +15.52% | +20.09% | +23.18% | +28.55% | +122.92% | +398.76% | +527.13% | 118B | |
| +0.23% | +6.17% | -2.61% | -1.11% | +2.01% | +13.94% | +27.30% | +5.73% | -10.60% | 99B | |
| +1.52% | +1.91% | -3.35% | -6.27% | -12.85% | -16.74% | -27.06% | -14.62% | +3.88% | 95.44B | |
| +4.07% | +6.15% | +47.29% | +267.02% | +669.38% | +772.32% | +175.45% | -31.99% | - | 90.58B | |
| -1.10% | +2.52% | -0.36% | +15.57% | +1.32% | +35.29% | -3.29% | +41.65% | +112.30% | 78.09B | |
| -0.03% | +5.09% | +9.05% | +7.15% | +17.94% | +28.02% | -2.82% | -26.99% | +45.69% | 70.41B | |
| +1.52% | +4.21% | -3.31% | -13.07% | -21.99% | -8.94% | +41.38% | +62.05% | +437.33% | 65.79B | |
| Average | +0.34% | +2.58% | +4.58% | +18.20% | +43.58% | +60.09% | +44.87% | +80.64% | +230.07% | 255.14B | |
| Weighted average by Cap. | +0.61% | +2.39% | +3.98% | +10.79% | +27.35% | +45.44% | +63.17% | +145.27% | +450.65% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
